The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the commercial efforts uh which there are of which are many uh are largely they're not planning on doing this large these large randomized trials like the ldc lotus ct study we showed we talked about earlier that proved that that you save lives from lung cancer why not well they are expensive and take years right and so it's not attractive from an investment standpoint
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.